Please login to read the full article.
Scrip Regulatory Affairs
Assessing the size of the US recall issue
27 April 2011
Ashley Yeo
Please login to read the full article.
Not a subscriber ? Request a FREE Trial
Subscribe to Regulatory Affairs Pharma
RELATED CONTENT
NEWS
Scrip Regulatory Affairs News
- US FDA orders post-market surveillance for metal-on-metal hips
- US FDA action on drug shortages yields results, agency improves user fee goals
- US bill proposes conditional clearance authority for FDA's 510(k) process
- Australian govt releases regulatory reforms for pharma and medtech; industries raise concerns
Other Informa News
ANALYSIS
Regulatory Affairs Pharma Analysis
Other Informa Analysis
EDITORIALS
Regulatory Affairs Pharma Editorials
Other Informa Editorials
FEATURES
Regulatory Affairs Pharma Features
Other Informa Features
COMMENT
Regulatory Affairs Pharma Comment
Other Informa Comments
